We have recently shown that in melanoma, PAK4 overexpression is associated with lack of immune cell infiltration and resistance to PD-1 blockade immunotherapy, with its inhibition resulting in increased immune cell infiltration leading to overcoming resistance to anti-PD-1 therapy (13). This evidence concerns the gene PAK4 and melanoma.